Sarah Nell Inamander
Senior Director of Investor Relations
Replay available
Zymeworks Inc. (ZYME) Q3 2025 Earnings Call
Zymeworks Inc. (NASDAQ: ZYME) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Leonie Patterson
Executive Vice President and Chief Business and Financial Officer
Dr. Sabine McCann
Senior Vice President of Clinical Development
Dr. Paul Moore
Chief Scientific Officer
Ken Galbraith
Chair and Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Zymeworks Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.297 Thank you for standing by. This is the conference operator. 00:00:04.297 -- 00:00:09.405 Welcome to the ZineWorks third quarter 2025 00:00:09.405 -- 00:00:14.492 results conference call and webcast. As a reminder, all participants are in 00:00:14.492 -- 00:00:18.317 a listen-only mode, and the conference is being recorded. 00:00:18.317 -- 00:00:22.123 After the presentation, there will be an opportunity to ask questions. 00:00:22.123 -- 00:00:27.230 To ask a question, press star 11 on your telephone keypad. 00:00:27.230 -- 00:00:31.725 Should you need assistance during the conference call, you may signal an operator by 00:00:31.725 -- 00:00:36.730 pressing star and then zero. I would now like to turn the conference over 00:00:36.730 -- 00:00:40.554 to Sarah Nell Inamander, 00:00:40.554 -- 00:00:43.155 Senior Director 00:00:44.618 -- 00:00:48.720 of Investor Relations. Please go ahead. 00:00:49.503 -- 00:00:52.426 Thank you, operator, and good afternoon, everyone. 00:00:52.426 -- 00:00:57.610 Thank you for joining our third quarter 2025 results conference call. 00:00:57.659 -- 00:01:01.944 As usual, before we begin, I'd like to remind you that we'll be making a number of forward-looking 00:01:01.944 -- 00:01:06.350 statements during this call, including without limitation, those forward-looking statements 00:01:06.350 -- 00:01:10.254 identified in our slides and the accompanying oral commentary. 00:01:10.254 -- 00:01:14.459 Forward-looking statements are based upon our current expectations and various assumptions 00:01:14.459 -- 00:01:18.464 and are subject to the usual risks and uncertainties associated with companies in our 00:01:18.464 -- 00:01:22.266 industry and at our stage of development. 00:01:22.769 -- 00:01:27.094 For disc...